Feeding a flavonoid to trick flax roots into making more anticancer lignan

Justicidin B is one of those molecules that makes medicinal chemists sit up and pay attention. It belongs to the arylnaphthalene lignans, a family of plant secondary metabolites built from the phenylpropanoid pathway, and decades of pharmacological testing have attributed pronounced anticancer, antiviral, antimicrobial, antioxidant, anti-inflammatory, and antiparasitic activities to it. The catch is supply. Plants make justicidin B only in trace amounts, wild populations of the species that accumulate it are limited in distribution, and extracting enough compound from natural tissues for drug development is neither practical nor sustainable. A new study from researchers working with in vitro root cultures of two European flax relatives, published in Pharmacia, now reports a deceptively simple intervention that significantly boosts justicidin B accumulation: feeding the cultures a flavonoid called vitexin, which appears to reroute the plant’s own metabolic traffic away from competing pathways and toward lignan biosynthesis.

The two species at the center of the work, Linum austriacum and Linum alpinum, are recognized as some of the richest natural sources of arylnaphthalene lignans. L. austriacum is among the most productive justicidin B-accumulating species known, while L. alpinum, a rare alpine endemic of European mountain regions, has recently emerged as an additional promising source of the same bioactive lignan. Because harvesting wild plants is constrained by the limited range of these species and the low natural abundance of justicidin B, the research team turned to in vitro root cultures, which combine genetic and biochemical stability with rapid growth and the capacity to maintain specialized metabolic pathways under fully controlled conditions. Root cultures are established from aseptically germinated seedlings and maintained on modified Murashige and Skoog medium supplemented with defined auxins and, in the case of L. alpinum, kinetin and casein hydrolysate, subcultured every 30 days to keep biomass development and metabolic state uniform before each experiment.

Understanding why vitexin was chosen requires a look at the architecture of the phenylpropanoid pathway itself. This central metabolic network originates from phenylalanine and proceeds through cinnamic acid, p-coumaric acid, caffeic acid, ferulic acid, and coniferyl alcohol before the sequential formation of pinoresinol, lariciresinol, and secoisolariciresinol, ultimately yielding arylnaphthalene lignans including justicidin B. Crucially, the same pathway also gives rise to flavonoids and numerous other phenolic compounds, so the relative activity of competing branches plays a decisive role in determining which end products accumulate. Flavonoids have traditionally been regarded as terminal products of phenylpropanoid metabolism, but increasing evidence suggests they also participate in metabolic crosstalk and signaling within the network. Vitexin, a naturally occurring C-glycosyl flavone, is a characteristic specialized metabolite of Linum species: it and related mono- and di-C-glycosyl flavones have been identified in the aerial tissues of cultivated flax, and high-resolution mass spectrometry profiling of other Linum species has revealed vitexin among the major detected compounds. Prior work showing that stress-induced accumulation of phenolics, flavonoids including vitexin, and lignans occurs together in Linum cell cultures further supported the close metabolic relationship between the two branches.

Before any supplementation, the researchers first mapped the endogenous accumulation of justicidin B in untreated root cultures of both species over a 30-day cultivation period, quantifying the compound by liquid chromatography coupled with high-resolution electrospray ionization mass spectrometry using an external calibration curve prepared from purified justicidin B. The two species told strikingly different stories. In L. alpinum root cultures, justicidin B was consistently detected and rose gradually from 0.07 micrograms per milligram dry weight on day 5 to a maximum of 0.12 micrograms per milligram dry weight on day 30, with no early accumulation maximum, indicating a slow and progressive trend. In L. austriacum, justicidin B was already present at relatively high levels during early culture development, reaching 1.19 micrograms per milligram dry weight on day 5, then declined to 0.75 on day 20 and bottomed out at 0.58 on day 25, a dip the authors associate with increased biomass development, before partially recovering to 0.72 by day 30. This profile established that justicidin B accumulation in L. austriacum varies with culture age rather than progressing steadily, and it identified day 25 as a suitable intervention point, a phase of reduced endogenous production where the effect of an external supplement could be cleanly evaluated.

The first supplementation experiment applied vitexin at final concentrations of 1, 3, and 5 micromolar to root cultures of both species on cultivation day 25, with harvest after 5 days of treatment on day 30. Each treatment was performed in triplicate, and ethanol-treated cultures were included as solvent controls to distinguish the effects of vitexin from those of the solvent, since stock solutions were prepared in absolute ethanol and diluted with sterile distilled water immediately before use. The ethanol control proved statistically inert in every comparison, confirming that any changes in justicidin B content could be attributed to the flavonoid itself. The results were species-specific in a way that defied a simple concentration-response curve. In L. alpinum, 1 micromolar vitexin produced the highest justicidin B accumulation at 0.14 micrograms per milligram dry weight, roughly a 1.2-fold increase over the untreated control, while higher concentrations of 3 and 5 micromolar yielded contents comparable to controls, indicating that increasing the dose beyond 1 micromolar did not further enhance accumulation in this species.

L. austriacum responded far more dramatically. Supplementation with 1 micromolar vitexin increased justicidin B content to 0.93 micrograms per milligram dry weight, a tendency that fell just short of statistical significance, and 3 micromolar produced 0.86, but the strongest response came at 5 micromolar, where justicidin B reached 1.30 micrograms per milligram dry weight, an approximately 1.8-fold increase over the untreated control that was highly significant. Notably, 3 micromolar did not produce an intermediate response between 1 and 5 micromolar, so vitexin did not induce a simple dose-dependent pattern across the tested range. The authors interpret this as evidence that the effect depends on the metabolic capacity and physiological state of each root culture system, consistent with the known influence of genotype, culture conditions, and treatment optimization on secondary metabolite production in plant in vitro systems.

Because L. austriacum had shown the stronger response, the team extended the work with a prolonged supplementation experiment using higher concentrations and later cultivation stages. Independent sets of cultures were supplemented with 5 or 10 micromolar vitexin on day 30 and harvested on day 35, or supplemented on day 35 and harvested on day 40, again following 5 days of treatment. On day 35, 10 micromolar vitexin significantly increased justicidin B accumulation to 1.45 micrograms per milligram dry weight, approximately 2.4-fold above the untreated control, the strongest effect recorded anywhere in the study. On day 40, however, the picture reversed: 5 micromolar vitexin left justicidin B levels comparable to controls at 1.24 micrograms per milligram dry weight, and 10 micromolar actually produced a slight reduction to 1.01, lower than both the untreated and ethanol-treated controls. This shift demonstrates that the optimal vitexin concentration changes during culture development and that the response is tightly linked to the physiological state of the cultures, with the same dose that strongly supports accumulation at one stage potentially inhibiting the phenylpropanoid pathway at a later one.

The mechanistic hypothesis the authors propose is what makes the study conceptually novel. Vitexin is not a direct biosynthetic precursor of justicidin B, so the observed increases cannot be explained by precursor feeding in the classical sense. Instead, the external supply of vitexin may act through feedback-related modulation of the flavonoid branch of the phenylpropanoid pathway: flooding the cultures with a flavonoid end product may suppress or partially block further metabolic activity toward flavonoid biosynthesis, allowing shared phenylpropanoid intermediates such as coniferyl alcohol to be preferentially directed toward the lignan branch and ultimately toward arylnaphthalene lignan production. In effect, inhibiting a competitive metabolic pathway promotes justicidin B accumulation, exactly as the study’s title suggests. The cultivation-stage-dependent response in L. austriacum further indicates that this redirection is influenced by the physiological state of the cultures and by the applied concentration, emphasizing the importance of optimizing both treatment timing and dose.

The authors are careful to stress that this mechanism remains hypothetical. Future experiments should include targeted metabolomic profiling of flavonoid and lignan intermediates, expression analysis of key genes involved in both branches, and enzyme activity assays for relevant phenylpropanoid pathway enzymes to clarify whether the increased justicidin B accumulation truly results from redirected metabolic activity toward arylnaphthalene lignan biosynthesis. Such analyses would confirm whether exogenous flavonoid supplementation suppresses flavonoid biosynthesis and promotes justicidin B production at the molecular and enzymatic levels, converting a promising correlation into a demonstrated regulatory interaction.

Even with that caveat, the practical implications are considerable. To the best of current knowledge, this is the first study demonstrating that exogenous supplementation with the flavonoid vitexin can influence justicidin B accumulation in Linum root cultures, introducing a novel strategy for enhancing arylnaphthalene lignan production through flavonoid-mediated regulation of the phenylpropanoid pathway. The findings highlight the importance of species-specific metabolic capacity, vitexin concentration, and treatment timing, with L. austriacum root cultures treated with 10 micromolar vitexin on day 30 delivering the highest fold increase in the study. For a compound with such pronounced pharmacological potential and such limited natural availability, a controlled in vitro system that can be steered toward higher lignan output by a single well-timed flavonoid supplement represents a meaningful step toward sustainable biotechnological production, and it opens a new line of inquiry into how the competing branches of one of plant biology’s central metabolic networks can be manipulated by the very molecules they produce.

Subject of Research: Flavonoid-mediated metabolic rerouting enhances anticancer lignan production in Linum root cultures

Article Title: Inhibition of competitive metabolic pathways promotes lignan accumulation in Linum in vitro root cultures

Article References: Zarev, Y., Nedelcheva, R., & Ionkova, I. (2026). Inhibition of competitive metabolic pathways promotes lignan accumulation in Linum in vitro root cultures. Pharmacia, 73, Article e206408. https://doi.org/10.3897/pharmacia.73.e206408

Image Credits: AI Generated

DOI: 10.3897/pharmacia.73.e206408

Keywords: lignans, justicidin B, Linum, vitexin, phenylpropanoid pathway, plant biotechnology, in vitro root cultures, secondary metabolites, Inhibition, competitive, metabolic, pathways